Welcome to Money Morning - Only the News You Can Profit From.

Close

This Tech-Sector David is About to Club Goliath

Not a member yet? Right now you can get immediate access to Money Morning’s Private Briefing for only $7.99. Click here to get started now.

  • TODAY’SPRIVATE BRIEFING arrow

best short term investments- Money Morning - Only the News You Can Profit From.

  • Best Investments 2013: Beat Bernanke by Embracing the Free Market

    For the last four years, ordinary Americans have struggled to rebuild their wealth in the wake of the Great Financial Crisis.

    Last week, the Federal Reserve Bank of St. Louis reported that the average U.S. household has recovered only 45% of its wealth lost during the recession.

    Of course, the Federal Reserve won't acknowledge that its Chairman, Ben Bernanke, has been a principle driver in the underperformance of the middle class' return to financial normalcy. Bernanke has removed incentives for anyone to keep their dollars in a savings account by knocking interest rates to near-record lows.

    Meanwhile, nearly 50% of Americans do not own any stocks or bonds. Given recent memories of their wealth evaporating, it's been difficult to instill much confidence for those who lost so much.

    Low rates and lost confidence in the markets have left more Americans vulnerable to inflation, accelerating costs of staples, and uncertainty about their financial future.

    But there is good news.

    To continue reading, please click here...

  • Best Investments: How China's Creating a Huge Market for These Metals

    Looking for some of the best investments in metals?

    Don't overlook palladium and platinum, key materials used in building catalytic converters.
    Demand for the metals - and prices - will take off.

    We asked Rick Rule, the founder of Sprott Asset Management's Global Companies unit, to explain why.

    Rule told Money Morning in the following interview the prices will rise partly because demand for palladium and platinum will grow as a result of what's happening in the automobile market in China, now the largest automaker in the world.

    Here's why these metals could be the best investments you make in 2013.

  • Best Investments: Don't Miss the Next Raging Bull Market in Uranium

    Investors who bought into uranium at the right time in the 1970s probably considers it one of the best investments they've ever made...

    When the element entered a bull market in the '70s, the result was 10-fold gains for uranium prices, and 100-fold gains for related uranium stocks.

    Now the stage is set for uranium's price to go on another tear...

    To find out why uranium could be one of the best investments over the next few years, we turned to Rick Rule, founder and chairman of Sprott Global Resources Investments.

    To continue reading, please click here...

  • Some of the Best Investments for Doubling Your Money Are in Biotech

    Innovation is the mother of lucrative investing, and nowhere is that truer than in biotech - which delivers some of the best investments you'll ever find.

    Biotechnology provides breakthrough products and technologies to combat debilitating and rare ailments, it reduces rates of infectious disease, tailors treatments to individuals to minimize health risks and side effects, creates more precise tools for disease detection, and it reduces the odds of global life threatening conditions.

    In short, biotech helps to heal the world.

    "If you're looking to double your money, the biotech sector is one of the best hunting grounds that you'll find," writes Money Morning Tech Specialist Michael A. Robinson, who regularly follows the industry's best investments for his Strategic Tech Investor members.

    p>To continue reading, please click here…

  • Best Investments 2013: Finding Opportunity Far and Near

    Samuel Johnson once said, "The use of traveling is to regulate imagination by reality, and instead of thinking how things may be, to see them as they are."

    Although penned by an 18th century English writer, the idea holds true in today's highly connected world of search bars, tweets and breaking news. Our portfolio managers' research trips to foreign countries authenticates the data from a Bloomberg terminal or an earnings report. Treks add tacit knowledge to our wealth of explicit facts.

    Last week, I was in Peru and Colombia with former president Bill Clinton and Frank Giustra in conjunction with the Clinton Giustra Enterprise Partnership.

    I've been involved with this impressive organization since its inception. I love how it brings together private companies, government and communities in developing regions of the world to eradicate poverty by growing jobs and training local workers.

    To continue reading, please click here…

  • Best Investments 2013: Why Hedge Funds Love Greece

    Talk about looking for best investments in the most unlikely places...

    The bad economic news out of Greece has dominated the headlines for several years now. As the country tries to work its way back to prosperity, a solvent banking system is going to be critical to the process. Banks have seen their capital base shrink from bond haircuts, bad loans and depositors withdrawing money to get it outside the beleaguered nation's banking system.

    As part of its plan to restore the nation's fiscal health, Greece has told the banks they need to complete a recapitalization plan that raises Tier 1 capital ratios by 9%. This should increase their solvency and allow the nation to receive further bailout funds from the European Union.

    Restored capital levels should help the banks regain access to interbank markets and provide the liquidity needed to help push the economy back on track.

    To continue reading, please click here...

  • Follow Africa's Richest Man Into One of the Best Profit Opportunities on Earth

    Aliko Dangote is the richest man you've never heard of.

    The 56-year old native of Kano, Nigeria is a self-made business magnate, with a net worth of more than $16 billion.

    With boom times ahead for Africa, Dangote is leading the continent's headlong charge into infrastructure building and resource exploration.

    A person of vision and drive, he's well suited for the unfolding boom, and all the opportunity it offers.

    As the African Century moves into its second decade, Dangote is still very bullish on Africa-- making - and keeping - most of his fortune there.

    To continue reading, please click here...

  • Best Investments 2013: How the Mining Mess Will Send Platinum Soaring

    Thanks to the hit gold prices took in mid-April, other precious metals also got caught in the downdraft - but some still look to be among the best investments of 2013.

    Take platinum, for example.

    It is currently trading at about $1,500 an ounce, well off its 52-week high of $1,734 an ounce. During the height of the selloff last month, it touched a low of $1,381 an ounce.

    Investors sold it along with all other precious metals, even though the fundamentals for platinum may be better than ever.

    While platinum's long-term outlook is bright, a short-term price catalyst is about to take place, as early as this week.

    The world's biggest platinum producer, ANGLO American Platinum (Amplats), could take a significant amount of platinum off the market. The restructuring could cost 14,000 jobs and close two South African mines.

    It'll also help drive a supply deficit that will only expand in the years ahead, making platinum one of the best investments to make now before prices soar.

    No wonder Sprott Holdings' Rick Rule bought $280 million worth of platinum and palladium earlier this year...

    To continue reading, please click here...

  • The Best Sector to Invest in Now

    I try to keep a balanced portfolio, or at least one that isn't entirely concentrated in one sector.

    I like a lot of international holdings, especially from East Asia (but not particularly China itself) and I try to have at least some representation even in sectors that bore me utterly, like consumer packaged goods - Procter & Gamble (NYSE: PG). I know you've increased your dividend every year since 1954, which is a magnificent achievement, but I STILL can't get excited about your business!

    Some market sectors I have difficulty warming up to. Tech, for example, I find very difficult to analyze. If a company has the latest whizz-bang, I can't tell how the market will receive it. I can't tell how long market enthusiasm for it will last, and I can't tell how quickly competitors will produce something that's just a little bit better.

    Even an Apple (Nasdaq: AAPL) that appears to have an invulnerable position can very easily be undone by margin erosion. Apple's margins are unsustainable in a competitive environment; it has a business in which Foxconn, the manufacturer, makes very little money while Apple, the retailer, makes heaps of it. For me, instead of trading at a premium to the market because of its growth, tech should trade at a discount to the market because of its risks.

    To continue reading, please click here...

  • Best Investments 2013: This Could Be the Most Lucrative Time Ever for Biotech

    Some of the most exciting developments in the last fifty years have been in the biotechnology industry - which has also meant the emergence of some of the best investments for 2013.

    Just look at the progress biotech has made in medicine.

    Using advanced technology and research, scientists in the life sciences industry are working on cures for diseases that have plagued mankind for decades. In a relatively short period of time, biotechnology has produced medications that have pushed many forms of cancer to the brink of defeat. HIV infection went from a death sentence to a manageable - and almost cured - condition, in just a few decades.

    Biotech share prices have reflected these successes.

    As Barron's pointed out last week, biotech stocks have soared 111% over the past couple years, about three times better than healthcare stocks.

    And early investors in biotech have seen astronomical gains over the past four to five years.

    Regeneron Pharmaceuticals Inc. (Nasdaq: REGN) has soared from less than $5 a share back in 2005 to more than $240 a share today as its drugs have been used to battle ophthalmological disease and several forms of cancer. Incyte Corp. (Nasdaq: INCY) has seen its stock price rise from $2 a share just four years ago to more than $20 today. Early investors in industry leader Amgen Inc. (Nasdaq: AMGN) have seen gains of almost 100 times their initial investment.

    But those gains are far from over.

    In fact, right now just may be the best time in history to be an investor in the biotechnology sector.

    To continue reading, please click here…

Show me